| 000 | 01213nam a2200121Ia 4500 | ||
|---|---|---|---|
| 008 | 220615s9999||||xx |||||||||||||| ||und|| | ||
| 245 | 0 | _aBotulinum Toxin Treatment for Pain and Inflammation in Functional Urological Disorders | |
| 546 | _aEnglish[eng] | ||
| 650 | _aurethra||onabotulinumtoxinA||voiding||therapeutic outcome||lower urinary tract symptoms||botulinum toxin||benign prostatic hyperplasia||prostatitis||inflammation||Botulinum toxin||chronic prostatitis||interstitial cystitis||treatment||bladder pain||botulinum toxin A||predictor||maximal bladder capacity||hydrodistention||urethral sphincter||urethral sphincter dysfunction||urodynamics||drug delivery||overactive bladder||painful bladder syndrome||molecular mechanism||chronic pelvic pain syndrome||pelvic pain||functional urology disorder||human||network meta-analysis||OnabotulinumtoxinA||peripheral tibial nerve stimulation||sacral neuromodulation||bladder||sensation||therapy||pathophysiology||diabetes mellitus||mid-urethral sling||antimuscarinics||urinary incontinence||functional urological disorders||pain||neurogenic detrusor overactivity | ||
| 700 | _aKuo, Hann-Chorng | ||
| 856 | _uhttps://mdpi.com/books/pdfview/book/2935 | ||
| 942 | _cEB | ||
| 999 |
_c12075 _d12075 |
||